Pharmaceutical Statistics

Cover image for Vol. 12 Issue 6

November/December 2013

Volume 12, Issue 6

Pages 333–393

  1. Viewpoint

    1. Top of page
    2. Viewpoint
    3. Main Papers
    4. Literature Review
    5. Letters to the Editor
    1. European Federation of Statisticians in the Pharmaceutical Industry's position on access to clinical trial data (pages 333–336)

      Christine Fletcher, Stefan Driessen, Hans Ulrich Burger, Christoph Gerlinger, Egbert Biesheuvel and on behalf of the EFSPI

      Version of Record online: 18 OCT 2013 | DOI: 10.1002/pst.1603

  2. Main Papers

    1. Top of page
    2. Viewpoint
    3. Main Papers
    4. Literature Review
    5. Letters to the Editor
    1. Adjusting overall survival for treatment switches: commonly used methods and practical application (pages 348–357)

      Claire Watkins, Xin Huang, Nicholas Latimer, Yiyun Tang and Elaine J. Wright

      Version of Record online: 18 OCT 2013 | DOI: 10.1002/pst.1602

    2. Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements (pages 366–374)

      Ruud Boessen, Frederieke van der Baan, Rolf Groenwold, Antoine Egberts, Olaf Klungel, Diederick Grobbee, Mirjam Knol and Kit Roes

      Version of Record online: 23 SEP 2013 | DOI: 10.1002/pst.1599

  3. Literature Review

    1. Top of page
    2. Viewpoint
    3. Main Papers
    4. Literature Review
    5. Letters to the Editor
    1. July 2013–September 2013 (pages 385–386)

      Tianhui Helen Zhou and Andrew Lloyd

      Version of Record online: 29 OCT 2013 | DOI: 10.1002/pst.1600

  4. Letters to the Editor

    1. Top of page
    2. Viewpoint
    3. Main Papers
    4. Literature Review
    5. Letters to the Editor
    1. Authors’ reply to the letter to the editor by Olivier J.M. Guilbaud (pages 390–393)

      Cheng Zheng, Jixian Wang and Lihui Zhao

      Version of Record online: 11 SEP 2013 | DOI: 10.1002/pst.1594

SEARCH

SEARCH BY CITATION